Navigation Links
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Date:8/4/2009

ry approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2008, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... , ... Most employers have been using multi-tier prescription drug plans for many ... significant increase in the use of 4-tier plans, which typically cover the highest cost ... is expected to continue, according to UBA. , UBA’s survey finds that, since 2009, ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... source for identifying Top Doctors, has based its selection process on the foundation ... outstanding in their medical specialties, in any area of medicine and in any ...
(Date:7/28/2015)... ... July 28, 2015 , ... Advanced Fertility Center of ... inception in 2010, and Dr Dozortsev , a Reproductive Laboratory Director at AFCT, ... 2012, he was succeeded by Dr Gianpiero Palermo, who is credited with the discovery ...
(Date:7/28/2015)... ... July 28, 2015 , ... American ... RN to BSN cohorts for Geisinger Health System (GHS), one of the ... and associate degree prepared nurses with access to American Sentinel’s affordable, flexible and ...
(Date:7/28/2015)... ... July 28, 2015 , ... North American Seminars will present ... of 2015 . These seventeen courses are pre-approved for CME credit for ... Mobility in the Older Adult , August 22, 2015 - August 23, ...
Breaking Medicine News(10 mins):Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8
... sales forces shrinking,across the pharmaceutical industry and physicians ... a place on hospital formularies has never been,more ... on,specialized training classes to help their reps better ... to recent,research from pharmaceutical benchmarking leader Best Practices, ...
... recent survey of 202 neonatologists and pediatricians, which examined ... health needs of preterm infants, revealed that most respondents ... not place enough emphasis on or dedicate enough resources ... by MedImmune, Inc. , The incidence of preterm birth, ...
... Feb. 19 Athletes for Life,Foundation (a District of ... ) have just completed their second mobile health screening ... largest such event in the,world, at its 35th anniversary., ... area donated,their time to care for the patients, conducting ...
... Transitionz Wellness,Boutique is a one-stop-shop for anyone, male ... survivor, is going through cancer treatments, or who ... and we are pleased to announce our Grand,Opening. ... services,including wigs, hats, turbans and scarves; breast forms, ...
... the brains of patients with schizophrenia also tend to ... the Silvio Conte Center for the Neuroscience of Mental ... Louis. Shape abnormalities were found in the brain,s thalamus. ... patients with schizophrenia and their non-affected siblings and compared ...
... in neurodevelopment may have yielded up a key secret. , ... says they have determined how events at the very tips ... back in the cell,s distant nucleus. , The study also ... that influence gene activity -- working outside the cell,s nucleus. ...
Cached Medicine News:Health News:Building an Effective Sales Force to Serve the U.S. Hospital Market 2Health News:Neonatologists and pediatricians highlight progress and barriers to preemie care 2Health News:Neonatologists and pediatricians highlight progress and barriers to preemie care 3Health News:Signalife & Athletes Foundation Complete Second Mobile Health Screening 2Health News:Signalife & Athletes Foundation Complete Second Mobile Health Screening 3Health News:Transitionz Wellness Boutique Launches with Grand Opening Discounts 2Health News:Siblings of schizophrenia patients display subtle shape abnormalities in brain 2Health News:Scientists shed light on long-distance signaling in developing neurons 2Health News:Scientists shed light on long-distance signaling in developing neurons 3
(Date:7/28/2015)... , July 28, 2015  ULURU Inc. (OTCQB: ULUR) ... Stockholders and the appointment of Bradley J. Sacks ... Company,s Board of Directors has determined that the 2015 Annual ... 25, 2015 at 10:00 a.m., Central Daylight Time at the ... TX 75001. In accordance with the ...
(Date:7/28/2015)... 2015  Cepheid (Nasdaq: CPHD ) today ... clinical molecular diagnostic system designed to meet the ... just 9 inches tall, and weighing just 2.2 ... high quality PCR-based Xpert® cartridges as Cepheid,s existing ... molecular diagnostic tests to be performed in any ...
(Date:7/28/2015)... , July 20, 2015 ... addition of the "Global Post-traumatic Stress Disorder Therapeutics ... The global PTSD therapeutics market to grow at a ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
Breaking Medicine Technology:ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 2ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 4Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2
... Inc. (NASDAQ: ARNA ) today announced that Robert ... Vice President, Finance and Chief Financial Officer. Mr. Hoffman served ... before departing in March to work for a private biopharmaceutical ... been a key contributor to Arena," said Jack Lief, Arena,s ...
... 2011 / PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: ... commercializing products targeting the extracellular matrix , today ... 2011 Life Sciences Conference in New York. The presentation ... EDT (6:10 a.m. PDT). To listen to the live ...
Cached Medicine Technology:Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 2Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 3Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17 2
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Open 15 mm blades allow intraocular manipulation without metal to metal contact. 16 mm lifting wings. Dull finish....
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Medicine Products: